Furthermore, the overexpression of SMC1A and SMC1B was significantly associated with poor OS and PFS, while elevated expression of SMC2 and SMC4 was associated with poorer OS, RFS, PFS, and DSS in HCC patients. Here, SMC1B is linked to hepatocellular carcinoma.